News & Events

All the latest news and events from PhoreMost

PhoreMost expands into new facility at Unity Campus, Cambridge, UK
18th January 2022

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

New state-of-the-art facility has been designed to support PhoreMost’s phenotypic screening expertise Investment in new headquarters and equipment forms part of ongoing company growth plans Cambridge, UK, 18 January 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has relocated its headquarters to Unity Campus …

Drug Discovery World feature article: ‘Target discovery and drug development – what comes after CRISPR?’
30th April 2020

Drug Discovery World feature article: ‘Target discovery and drug development – what comes after CRISPR?’

PhoreMost strengthens leadership team with two key appointments
3rd February 2020

PhoreMost strengthens leadership team with two key appointments

PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
21st January 2020

PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration
7th January 2020

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development
4th November 2019

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development

PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019
31st October 2019

PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019

No events currently available